Recent studies have shown that TUFT1 is an oncoprotein that promotes proliferation, metastasis, and drug resistance in breast cancer cells and is associated with worse clinical status and poor prognosis [38–40]. This evidence concerns the gene TUFT1 and breast carcinoma.